NFKB1 and brain neoplasm: Some of tetrahydroxycurcumin's anticancer effects in brain tumors have been mechanistically connected to its capacity to block NF‐κB (nuclear factor kappa‐light‐chain‐enhancer of activated B cells), a transcription factor that stimulates inflammation and cell survival.